We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.66%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$14B
AUM Growth
+$1.55B
(+12%)
Cap. Flow
+$55.8M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
20.04%
Holding
266
New
32
Increased
101
Reduced
90
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$114M |
| 2 |
Novartis
NVS
|
+$98.3M |
| 3 |
Carter's
CRI
|
+$80.1M |
| 4 |
Brixmor Property Group
BRX
|
+$77.5M |
| 5 |
Citigroup
C
|
+$75.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$340M |
| 2 |
Adobe
ADBE
|
+$106M |
| 3 |
Marriott International
MAR
|
+$99.8M |
| 4 |
Cisco
CSCO
|
+$81.3M |
| 5 |
Progressive
PGR
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.58% |
| 2 | Healthcare | 17.58% |
| 3 | Industrials | 13.74% |
| 4 | Financials | 11.64% |
| 5 | Consumer Discretionary | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $412M | 2.93% |
5,609,976
+46,432
| +0.8% | +$2.99M |
|
2
Alphabet (Google) Class A
GOOGL
$3.91T
| $350M | 2.49% |
5,219,540
+632,860
| +14% | +$40.8M |
|
3
Amazon
AMZN
$2.5T
| $318M | 2.26% |
3,439,940
-71,280
| -2% | -$6.31M |
|
4
Microsoft
MSFT
$2.84T
| $310M | 2.21% |
1,964,186
-297,913
| -13% | -$43.8M |
|
5
Meta Platforms (Facebook)
META
$1.51T
| $265M | 1.89% |
1,292,534
-13,087
| -1% | -$2.53M |
|
6
Visa
V
$677B
| $250M | 1.78% |
1,329,824
-35,309
| -3% | -$6.36M |
|
|
7
TransDigm Group
TDG
$69.2B
| $243M | 1.73% |
434,524
+207,933
| +92% | +$114M |
|
8
ServiceNow
NOW
$102B
| $224M | 1.59% |
3,964,880
+245,410
| +7% | +$12.9M |
|
9
Fidelity National Information Services
FIS
$21.5B
| $223M | 1.59% |
1,602,744
+21,268
| +1% | +$2.85M |
|
10
Teledyne Technologies
TDY
$30.4B
| $219M | 1.56% |
633,228
-20,857
| -3% | -$7.01M |
|
|
SPLK
11
DELISTED
Splunk Inc
SPLK
| $201M | 1.43% |
1,344,429
+548,012
| +69% | +$71.9M |
|
12
Salesforce
CRM
$134B
| $183M | 1.3% |
1,125,401
-5,338
| -0.5% | -$837K |
|
13
Trane Technologies
TT
$106B
| $181M | 1.29% |
1,360,059
-40,046
| -3% | -$5.07M |
|
14
Mettler-Toledo International
MTD
$26.8B
| $175M | 1.25% |
221,218
-4,445
| -2% | -$3.21M |
|
15
Ascendis Pharma A/S
ASND
$16.7B
| $175M | 1.25% |
1,260,756
+136,702
| +12% | +$15.2M |
|
16
Bio-Rad Laboratories Class A
BIO
$8.42B
| $170M | 1.21% |
460,629
+48,717
| +12% | +$17.2M |
|
17
Home Depot
HD
$332B
| $168M | 1.2% |
769,504
-28,952
| -4% | -$6.56M |
|
18
Ametek
AME
$55.5B
| $162M | 1.16% |
1,626,569
-171,288
| -10% | -$16.2M |
|
19
Marathon Petroleum
MPC
$90.3B
| $161M | 1.15% |
2,669,780
-70,217
| -3% | -$4.39M |
|
20
Global Payments
GPN
$22.1B
| $160M | 1.14% |
876,744
-21,772
| -2% | -$3.74M |
|
21
Vertex Pharmaceuticals
VRTX
$121B
| $157M | 1.12% |
717,668
-215,080
| -23% | -$43.5M |
|
22
L3Harris
LHX
$55.9B
| $149M | 1.06% |
754,494
-17,926
| -2% | -$3.6M |
|
23
Thermo Fisher Scientific
TMO
$211B
| $149M | 1.06% |
457,299
-10,177
| -2% | -$3.09M |
|
24
Applied Materials
AMAT
$426B
| $143M | 1.02% |
2,345,060
+309,354
| +15% | +$17.4M |
|
25
S&P Global
SPGI
$126B
| $135M | 0.96% |
494,162
+9,283
| +2% | +$2.41M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Westfield Capital Management held 266 positions worth $14B, up 12% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Westfield Capital Management's Q4 2019 filing shows 32 new, 101 increased, 90 reduced and 35 closed positions. Its largest new stake was Novartis: 1,095,518 shares worth $104M. The largest sale was Medicines Co, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2019 buy was Novartis: 1,095,518 shares worth $104M.
- Westfield Capital Management added most to TransDigm Group in Q4 2019, an estimated $114M increase.
- Westfield Capital Management's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $340M.
- Westfield Capital Management fully exited Adobe in Q4 2019, selling an estimated $106M.
- Westfield Capital Management's ten largest holdings make up 20% of its $14B portfolio in Q4 2019.
- Westfield Capital Management opened 32 new positions and closed 35 in Q4 2019.
- Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $14B.
Based on Westfield Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.